Future aspects of hemophilia research and care

Seminars in Thrombosis and Hemostasis

Volumn 32, Issue SUPPL. 2, 2006, Pages 32-38

  Valentino, Leonard A ^a   Scheiflinger, Friedrich ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b BAXTER BIOSCIENCE   (Austria)

Author keywords

Animal model; Hemophilic synovitis; Joint bleeding; Monoclonal antibodies

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8A; BLOOD CLOTTING FACTOR 9A; CYCLIN DEPENDENT KINASE INHIBITOR 1; DNA; FAS ANTIGEN; FERRIC CITRATE; FERRITIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IRON; MONOCLONAL ANTIBODY; MYC PROTEIN; RECOMBINANT BLOOD CLOTTING FACTOR 8; RNA;

ARTHRITIS; ARTHROPATHY; ARTICLE; BLOOD CLOTTING; CELL PROLIFERATION; FIBROBLAST; GENE THERAPY; GENETIC ENGINEERING; HEMARTHROSIS; HEMOPHILIA A; HEMOPHILIC SYNOVITIS; HUMAN; IN VITRO STUDY; IRON STORAGE; KNOCKOUT MOUSE; MEDICAL RESEARCH; MICROARRAY ANALYSIS; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNOVECTOMY; SYNOVIOCYTE; SYNOVITIS; THROMBIN TIME;

ANIMALS; ANTIBODIES, MONOCLONAL; DISEASE MODELS, ANIMAL; FACTOR VIII; HEMATOLOGY; HEMOPHILIA A; HUMANS; IRON; MICE;

EID: 33745714513     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-946913     Document Type: Article

References (22)

1. Bolton-Maggs PH, Pasi KJ. Haemophilias A and B. Lancet 2003;361:1801-1809
2. Valentino LA, Hakobyan N, Kazarian T, Jabbar KJ, Jabbar AA. Experimental haemophilic synovitis: rationale and development of a murine model of human factor VIII deficiency. Haemophilia 2004;10:280-287
3. Roosendaal G, Vianen ME, Wenting MJ, et al. Iron deposits and catabolic properties of synovial tissue from patients with haemophilia. J Bone Joint Surg Br 1998;80:540-545
4. Lan HH, Eustace SJ, Dorfman D. Hemophilic arthropathy. Radiol Clin North Am 1996;34:446-450
5. Morris CJ, Blake DR, Wainwright AC, Steven MM. Relationship between iron deposits and tissue damage in the synovium: an ultrastructural study. Ann Rheum Dis 1986; 45:21-26
6. Manco-Johnson MJ. Family issues in continuous infusion therapy with factor VIII. Blood Coagul Fibrinolysis 1996; 7(suppl 1):S21-S25
7. Hacker MR, Geraghty S, Manco-Johnson M. Barriers to compliance with prophylaxis therapy in haemophilia. Haemophilia 2001;7:392-396
8. Wen FQ, Jabbar AA, Chen YX, et al. c-myc proto-oncogene expression in hemophilic synovitis: in vitro studies of the effects of iron and ceramide. Blood 2002;100:912-916
9. Obeid LM, Linardic CM, Karolak LA, Hannun YA. Programmed cell death induced by ceramide. Science 1993; 259:1769-1771
10. Bi L, Lawler AM, Antonarakis SE, et al. Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nat Genet 1995;10:119-121
11. Bi L, Sarkar R, Naas T, et al. Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies. Blood 1996;88:3446-3450
12. Hakobyan N, Kazarian T, Jabbar AA, Jabbar KJ, Valentino LA. Pathobiology of hemophilic synovitis I: overexpression of mdm2 oncogene. Blood 2004;104:2060-2064
13. Wu KJ, Polack A, Dalla-Favera R. Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC. Science 1999;283:676-679
14. van Dieijen G, van Rijn JL, Govers-Riemslag JW, Hemker HC, Rosing J. Assembly of the intrinsic factor X activating complex-interactions between factor IXa, factor VIIIa and phospholipid. Thromb Haemost 1985;53:396-400
15. Rawala-Sheikh R, Ahmad SS, Ashby B, Walsh PN. Kinetics of coagulation factor X activation by platelet-bound factor IXa. Biochemistry 1990;29:2606-2611
16. Kerschbaumer RJ, Riedrich K, Krai M, et al. An antibody specific for coagulation factor IX enhances the activity of the intrinsic factor X-activating complex. J Biol Chem 2004;279: 40445-40450
17. Couto LB. Preclinical gene therapy studies for hemophilia using adeno-associated virus (AAV) vectors. Semin Thromb Hemost 2004;30:161-171
18. Gordon FH, Mistry PK, Sabin CA, Lee CA. Outcome of orthotopic liver transplantation in patients with haemophilia. Gut 1998;42:744-749
19. Schatz S, Turecek PL, Fiedler C, et al. Evaluation of the haemostatic potential of factor VIII-heparin cofactor II hybrid proteins in a mouse model. Br J Haematol 2003;123: 692-695
20. Hrachovinova I, Cambien B, Hafezi-Moghadam A, et al. Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nat Med 2003;9:1020-1025
21. Furie B, Furie BC. Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation. Trends Mol Med 2004;10:171-178
22. Rodriguez-Merchan EC, Magallon M, Galindo E, Lopez-Cabarcos C. Hemophilic synovitis of the knee and the elbow. Clin Orthop Relat Res 1997;343:47-53